Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, today announced it has secured Biomedical Catalyst funding of over 920,000 GBP from Innovate UK to create a safe, effective red blood cell substitute for human clinical transfusion, in collaboration with stem cell scientists at the University of Edinburgh. Over 90 million blood transfusions are carried out worldwide each [...]

Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline. “We are delighted to have put together this collaboration with has such enormous potential for the creation of next-generation stem cell [...]

Plasticell, the biotechnology company specialising in cell and gene therapy research, announces the completion of a two-part equity financing round, raising a total of £1.32 million from its shareholders and new investors. The investment will provide capital to progress the company’s therapeutic programmes, including the expansion of hematopoietic stem cells and in vitro manufacturing of blood products such as platelets, [...]

Plasticell, the biotechnology company using combinatorial technologies for stem cell research and optimization of cell and gene therapy manufacturing, has announced it is collaborating with CellSpring, an innovative company that has developed a high throughput 3D cell culture system, the 3D Bloom® Biopolymer Platform, which enables more informed “stop/go” decisions for preclinical candidates. Plasticell and CellSpring are developing tissue [...]

Plasticell, the biotechnology company using combinatorial technologies for stem cell research and the optimization of cell and gene therapy manufacturing, has announced the signing of a collaboration agreement with the National University of Ireland, Galway (NUI Galway) focused on methods of eradicating cancer stem cells. Many malignant tumors are initiated and maintained by a discrete population of tumour cells that [...]

Plasticell is pleased to announce it has been awarded the 2016 Queen’s Award for Enterprise in Innovation. The award is the UK’s highest accolade for outstanding commercial success as a result of innovation in recognition of Plasticell’s contribution to the advancement of regenerative medicine, cell and gene therapy as well as other areas of biomedical research. Dr. Yen Choo, Plasticell’s [...]

Plasticell, a biotechnology company using combinatorial cell culture technologies for optimization of cell and gene therapy manufacturing, has announced the signing of a collaboration agreement with Sphere Fluidics, a company specializing in single cell encapsulation and screening. Plasticell has used its proprietary Combinatorial Cell Culture™ (CombiCult®) platform to develop inexpensive, high-efficiency gene transduction protocols as alternatives to costly commercial transfection [...]

Plasticell, the biotechnology company specializing in stem cell differentiation, and Pierre Fabre, the 2ndlargest independent French Pharmaceutical laboratory, have today announced the signing of a collaboration agreement. The two companies will work together to discover plant-based products that enhance the metabolic function of brown adipose tissue (BAT) – also known as ‘brown fat’. Plasticell will screen Pierre Fabre’s ‘Nature Open [...]